- Home
- ZVIA vs NGNE Comparison
ZVIA vs NGNE Comparison
Compare ZVIA & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVIA
- NGNE
- Stock Information
- Founded
- ZVIA 2007
- NGNE 2003
- Country
- ZVIA United States
- NGNE United States
- Employees
- ZVIA N/A
- NGNE N/A
- Industry
- ZVIA Beverages (Production/Distribution)
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- ZVIA Consumer Staples
- NGNE Health Care
- Exchange
- ZVIA Nasdaq
- NGNE Nasdaq
- Market Cap
- ZVIA 266.6M
- NGNE 230.0M
- IPO Year
- ZVIA 2021
- NGNE N/A
- Fundamental
- Price
- ZVIA $3.79
- NGNE $18.08
- Analyst Decision
- ZVIA Hold
- NGNE Strong Buy
- Analyst Count
- ZVIA 4
- NGNE 6
- Target Price
- ZVIA $2.69
- NGNE $60.80
- AVG Volume (30 Days)
- ZVIA 947.7K
- NGNE 214.1K
- Earning Date
- ZVIA 02-25-2025
- NGNE 11-18-2024
- Dividend Yield
- ZVIA N/A
- NGNE N/A
- EPS Growth
- ZVIA N/A
- NGNE N/A
- EPS
- ZVIA N/A
- NGNE N/A
- Revenue
- ZVIA $153,385,000.00
- NGNE $925,000.00
- Revenue This Year
- ZVIA N/A
- NGNE N/A
- Revenue Next Year
- ZVIA $7.90
- NGNE N/A
- P/E Ratio
- ZVIA N/A
- NGNE N/A
- Revenue Growth
- ZVIA N/A
- NGNE N/A
- 52 Week Low
- ZVIA $0.62
- NGNE $14.42
- 52 Week High
- ZVIA $4.99
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- ZVIA 44.68
- NGNE 46.03
- Support Level
- ZVIA $3.60
- NGNE $15.16
- Resistance Level
- ZVIA $4.51
- NGNE $16.70
- Average True Range (ATR)
- ZVIA 0.34
- NGNE 1.18
- MACD
- ZVIA -0.14
- NGNE 0.45
- Stochastic Oscillator
- ZVIA 13.67
- NGNE 77.44
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.